Export 13 results:
Author Title [ Type(Desc)] Year
Filters: Author is Sallo, Ferenc B  [Clear All Filters]
Journal Article
F. B. Sallo, Leung, I., Zeimer, M., Clemons, T. E., Dubis, A. M., Fruttiger, M., Pauleikhoff, D., Chew, E. Y., Egan, C., Peto, T., and Bird, A. C., ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA., Retina, vol. 38 Suppl 1, pp. S79-S88, 2018.
K. Balaskas, Leung, I., Sallo, F. B., Clemons, T. E., Bird, A. C., and Peto, T., Associations between autofluorescence abnormalities and visual acuity in idiopathic macular telangiectasia type 2: MacTel project report number 5., Retina, vol. 34, no. 8, pp. 1630-6, 2014.
I. Leung, Sallo, F. B., Bonelli, R., Clemons, T. E., Pauleikhoff, D., Chew, E. Y., Bird, A. C., and Peto, T., CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA., Retina, vol. 38 Suppl 1, pp. S43-S50, 2018.
E. Y. Chew, Clemons, T. E., Peto, T., Sallo, F. B., Ingerman, A., Tao, W., Singerman, L., Schwartz, S. D., Peachey, N. S., and Bird, A. C., Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial., Am J Ophthalmol, vol. 159, no. 4, pp. 659-666.e1, 2015.
T. Peto, Heeren, T. F. C., Clemons, T. E., Sallo, F. B., Leung, I., Chew, E. Y., and Bird, A. C., CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group., Retina, vol. 38 Suppl 1, pp. S8-S13, 2018.
F. B. Sallo, Leung, I., Clemons, T. E., Peto, T., Chew, E. Y., Pauleikhoff, D., and Bird, A. C., CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA., Retina, vol. 38 Suppl 1, pp. S27-S32, 2018.
F. B. Sallo, Peto, T., Egan, C., Wolf-Schnurrbusch, U. E. K., Clemons, T. E., Gillies, M. C., Pauleikhoff, D., Rubin, G. S., Chew, E. Y., and Bird, A. C., "En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia., Invest Ophthalmol Vis Sci, vol. 53, no. 10, pp. 6145-52, 2012.
R. Bonelli, Ansell, B. R. E., Lotta, L., Scerri, T., Clemons, T. E., Leung, I., Peto, T., Bird, A. C., Sallo, F. B., Langenberg, C., and Bahlo, M., Genetic disruption of serine biosynthesis is a key driver of macular telangiectasia type 2 aetiology and progression., Genome Med, vol. 13, no. 1, p. 39, 2021.
M. Niskopoulou, Balaskas, K., Leung, I., Sallo, F. B., Clemons, T. E., Bird, A. C., and Peto, T., Is indocyanine green angiography useful for the diagnosis of macular telangiectasia type 2?, Br J Ophthalmol, vol. 97, no. 7, pp. 946-8, 2013.
F. B. Sallo, Peto, T., Egan, C., Wolf-Schnurrbusch, U. E. K., Clemons, T. E., Gillies, M. C., Pauleikhoff, D., Rubin, G. S., Chew, E. Y., and Bird, A. C., The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia., Invest Ophthalmol Vis Sci, vol. 53, no. 12, pp. 7889-95, 2012.
F. B. Sallo, Leung, I., Clemons, T. E., Peto, T., Bird, A. C., and Pauleikhoff, D., Multimodal imaging in type 2 idiopathic macular telangiectasia., Retina, vol. 35, no. 4, pp. 742-9, 2015.
U. E. K. Wolf-Schnurrbusch, Leung, I., Sallo, F. B., Clemons, T. E., Chew, E. Y., Bird, A. C., and Peto, T., Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia., Ophthalmic Res, vol. 60, no. 1, pp. 38-42, 2018.
F. B. Sallo, Leung, I., Chung, M., Wolf-Schnurrbusch, U. E. K., Dubra, A., Williams, D. R., Clemons, T., Pauleikhoff, D., Bird, A. C., and Peto, T., Retinal crystals in type 2 idiopathic macular telangiectasia., Ophthalmology, vol. 118, no. 12, pp. 2461-7, 2011.